Price Alert

Cardinal Health Inc. (CAH)

NYSE: CAH · Real-Time Price · USD

149.78

-0.44 (-0.29%)

At close: Aug 15, 2025, 12:46 PM

Cardinal Health Income Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Revenue	60.16B	54.88B	55.26B	52.28B	59.87B	54.91B	57.45B	54.76B	53.45B	50.49B	51.47B	49.6B	47.1B	44.84B	45.46B	43.97B	42.59B	39.27B	41.54B	39.06B
Cost of Revenue	57.96B	52.76B	53.32B	50.38B	58.06B	53.03B	55.6B	52.99B	51.63B	48.7B	49.81B	47.99B	45.5B	43.15B	43.84B	42.33B	41.11B	37.46B	39.77B	37.35B
Gross Profit	2.2B	2.12B	1.94B	1.9B	1.81B	1.88B	1.85B	1.74B	1.83B	1.78B	1.66B	1.61B	1.6B	1.68B	1.62B	1.64B	1.48B	1.81B	1.78B	1.72B
Operating Income	718M	730M	549M	568M	408M	369M	505M	-14M	137M	572M	408M	344M	333M	463M	-950M	415M	162M	473M	461M	-624M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	384M	665M	511M	541M	396M	341M	512M	-26M	121M	544M	-137M	110M	-28M	-137M	-973M	369M	119M	440M	427M	-663M
Net Income	239M	506M	400M	416M	236M	258M	353M	5M	-64M	345M	-130M	110M	138M	-1.39B	49M	271M	116M	119M	629M	-253M
Selling & General & Admin	1.48B	1.31B	1.31B	1.28B	1.28B	1.27B	1.27B	1.19B	1.27B	1.18B	1.19B	1.2B	1.16B	1.14B	1.15B	1.11B	1.13B	1.12B	1.15B	1.14B
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	78M	86M	57M	n/a	297M	78M	589M	-1M	74M	71M	71M	87M	79M	13M	4M	16M	12M	12M	7M
Operating Expenses	1.48B	1.39B	1.39B	1.33B	1.28B	1.57B	1.35B	1.77B	1.34B	1.25B	1.26B	1.27B	1.24B	1.22B	1.23B	1.19B	1.24B	1.23B	1.26B	1.25B
Interest Expense	74M	74M	35M	32M	13M	36M	8M	14M	27M	28M	25M	25M	39M	38M	37M	40M	44M	45M	46M	45M
Selling & Marketing Expenses	n/a	1.31B	1.31B	1.28B	1.24B	1.28B	1.28B	1.2B	n/a	1.18B	1.19B	1.2B	1.16B	1.14B	1.15B	1.11B	n/a	1.12B	1.15B	1.14B
Cost & Expenses	59.44B	54.15B	54.63B	51.71B	59.34B	54.31B	56.95B	54.68B	52.96B	49.95B	51.07B	49.26B	46.74B	44.37B	45.07B	43.52B	42.35B	38.69B	41.03B	38.6B
Income Tax Expense	141M	157M	110M	124M	162M	80M	136M	-32M	187M	197M	-7M	-1M	-165M	1.25B	-1.02B	97M	4M	320M	-203M	-410M
Shares Outstanding (Basic)	239M	240M	242M	243M	244M	243M	245M	249M	254M	256M	261M	271M	273M	275M	279M	287M	290M	292M	294M	293M
Shares Outstanding (Diluted)	240M	241M	243M	245M	245M	245M	246M	250M	254M	258M	261M	273M	275M	275M	281M	289M	293M	294M	295M	293M
EPS (Basic)	1.00	2.11	1.65	1.71	0.96	1.07	1.50	0.02	-0.25	1.35	-0.5	0.41	0.51	-5.05	0.17	0.94	0.40	0.41	2.14	-0.86
EPS (Diluted)	1.00	2.10	1.65	1.70	0.96	1.07	1.50	0.02	-0.25	1.34	-0.5	0.40	0.50	-5.05	0.17	0.94	0.40	0.40	2.13	-0.86
EBITDA	667M	730M	738M	755M	590M	547M	673M	160M	324M	747M	58M	306M	190M	82M	-772M	655M	343M	684M	672M	-413M
EBIT	458M	739M	546M	573M	392M	370M	498M	-12M	136M	572M	-112M	135M	6M	-99M	-936M	409M	163M	485M	473M	-618M
Depreciation & Amortization	209M	-9M	192M	182M	186M	177M	175M	172M	176M	175M	170M	171M	179M	181M	164M	246M	180M	199M	199M	205M